[rev_slider alias="home_new"]

ELUTE fiber provides pharmaceutical, therapeutic, and medical device companies with cutting-edge biodegradable polymers for implantable drug delivery.

TissueGen’s patented extrusion process enables delivery of the broadest range of temperature-sensitive pharmaceuticals and biologics previously impossible to incorporate in implantable devices. In more ways than ever, medical device developers can now deploy advanced drug delivery with ELUTE® fiber – an incredible breakthrough that drastically expands the drugs deliverable via implantable fibers.

LEARN MORE

ELUTE® Fiber

ELUTE® FIBER APPLICATIONS

TissueGen’s ELUTE fiber is ideally suited for a broad range of clinical applications and enables drug delivery from implantable devices for many therapeutic indications.

Advanced Drug Delivery

TissueGen’s patented room temperature fiber extrusion technology  preserves the biological activity of incorporated drugs and enables an entirely new format for drug delivery via biodegradable ELUTE fibers.
Learn More

Nerve Regeneration

Nerve Regeneration

ELUTE fiber is driving a paradigm shift in nerve regeneration through controlled, sustained delivery of sensitive biologics including growth  factors from biomimetic three-dimensional structures.
Learn More

Tissue Engineering

Tailored for devices that require both mechanical and pharmaceutical support,  ELUTE fiber is ideal for tissue scaffolds and stents, including TissueGen’s ARCHER™ stent and drug-eluting stent for the biliary, PAD, and DVT markets.
Learn More

TissueGen Wins MedTech Breakthrough Award

LEARN MORE

Upcoming Events

  • BIOMEDevice Boston

    April 18-19, 2018 Boston, MA Dr. Kevin Nelson will be presenting on “Enabling the Next Generation of Drug Delivery through Implantable Medical Devices” at 11:30 AM on April 18th. Learn more here....

Recent Awards

TissueGen has won the 2017 Future Textiles Award  for Most Innovative Small Company! Check out the video recap here

Latest News

TissueGen Founder and CSO Dr. Kevin Nelson to Present “Enabling the Next Generation of Drug Delivery through Implantable Medical Devices” Session at BIOMEDevice Boston
WHO: TissueGen® Inc., developer of ELUTE® fiber, enables controlled sustained delivery of sensitive pharmaceuticals and biologics from biodegradable fibers for advanced drug delivery, nerve regeneration and tissue engineering. TissueGen works with leading pharmaceutical, therapeutic and medical device companies to develop fiber and textile medical devices for use in drug...
BIOMEDevice Boston
April 18-19, 2018 Boston, MA Dr. Kevin Nelson will be presenting on “Enabling the Next Generation of Drug Delivery through Implantable Medical Devices” at 11:30 AM on April 18th. Learn more here.

White Paper

Controlled Sustained Delivery of Biologics and Pharmaceuticals from ELUTE® Fiber Enabling the Future of Medicine

Click Here to Read More

WEBCAST

BioPharma Dealmakers: New Innovations in Drug Delivery Technology Webinar

This webcast will highlight how innovative new approaches to biologic and pharmaceutical delivery may enable breakthroughs in oncology, treatment of CNS diseases and women’s health. Presented technologies will include fiber-based drug delivery for implantable and topical devices, digitally controlled needle-free devices, sustained and controlled transdermal delivery technology, targeted penetration matrix technology for non-invasive delivery and location-specific nano machines for chemotherapy payload delivery.

Signup for Our eNewsletter

Signup today for the latest news and updates from TissueGen.

Click Here to Subscribe